宁德时代目标涨幅超20%，山鹰国际、中顺洁柔评级被调低

Core Viewpoint - On May 21, 2023, brokerage firms issued a total of 28 target price recommendations for listed companies, with notable increases in target prices for companies in the chemical pharmaceutical, automotive parts, and software development sectors [1][2]. Group 1: Target Price Increases - The companies with the highest target price increases include: - Jianyou Co., Ltd. (603707) with a target price increase of 57.27% [1][2] - Aikedi (600933) with a target price increase of 38.45% [1][2] - Anheng Information (688023) with a target price increase of 38.20% [1][2] Group 2: Brokerage Recommendations - A total of 66 listed companies received brokerage recommendations on May 21, with the following companies receiving two recommendations each: - Aters (688472) in the photovoltaic equipment sector [3] - Ningde Times (300750) in the battery sector [3] - Beifang Huachuang (002371) in the semiconductor sector [3] Group 3: Rating Adjustments - One company had its rating upgraded: - Weicai Technology (688372) was upgraded from "Hold" to "Buy" by Tianfeng Securities [4][5] - Three companies had their ratings downgraded: - Shanying International (600567) downgraded from "Strong Buy" to "Recommended" by Huachuang Securities [6] - Zhongshun Jierou (002511) downgraded from "Strong Buy" to "Recommended" by Huachuang Securities [6] - Kecuan Technology (603052) downgraded from "Buy" to "Hold" by Zheshang Securities [6] Group 4: First Coverage - Ten companies received first-time coverage from brokerages: - Jinxichazhou (600495) rated "Hold" by Shanxi Securities in the rail transit equipment sector [7] - Changjiang Media (600757) rated "Buy" by Guohai Securities in the publishing sector [7] - Shenghe Resources (600392) rated "Recommended" by Minsheng Securities in the minor metals sector [7] - Hangcha Group (603298) rated "Hold" by Shanxi Securities in the engineering machinery sector [7] - Mayinglong (600993) rated "Hold" by China Merchants Securities in the traditional Chinese medicine sector [7] - Huana Pharmaceutical (688799) rated "Buy" by Huayuan Securities in the chemical pharmaceutical sector [7] - Zhimai Intelligent (001339) rated "Outperform" by Guoxin Securities in the computer equipment sector [7] - Dingzhi Technology (873593) rated "Hold" by Huayuan Securities in the automation equipment sector [7] - Dong'e Ejiao (000423) rated "Hold" by Nomura Orient International Securities in the traditional Chinese medicine sector [7] - Haibo Intelligent (688411) rated "Outperform" by China International Finance in the other power supply equipment sector [7]